Reimbursement Briefs: CMS Restricts Coverage For PILD Spine Surgery; OIG News
This article was originally published in The Gray Sheet
Executive Summary
Medicare will only cover percutaneous image-guided lumbar decompression as part of qualifying clinical trials under a final national coverage determination. OIG scrutinizes Medicare Administrative Contractor performance and local coverage determination inconsistencies. More reimbursement briefs.
You may also be interested in...
Ex-CMS Louis Jacques On Partnering With FDA And Keeping It Local
In this second portion of a two-part Q&A with Louis Jacques, he talks to “The Gray Sheet” about the importance of CMS’ growing collaboration with FDA, tensions between national and local Medicare coverage policymaking and the impact of resource constraints on CMS. Jacques left his post as CMS coverage director last month.
Spine Firms Laud CMS’ Decision To Cover Percutaneous Lumbar Decompression In Trials
Spinal device makers, who objected to CMS’ proposal for outright noncoverage of percutaneous image-guided lumbar decompression, are pleased with the agency’s final decision to cover PILD when provided in a clinical study through coverage with evidence development.
Spine Firms Make Last-Ditch Appeals For CMS Support Of Percutaneous Lumbar Decompression
Two medical device makers that stand to lose under CMS’ proposed noncoverage of percutaneous image-guided lumbar decompression say the agency’s proposal would unwisely eliminate a promising alternative to invasive surgery for the treatment of lumbar spinal stenosis. One suggests coverage with evidence development to allow more data collection, an approach also advocated by the North American Spine Society.